scholarly article | Q13442814 |
P50 | author | Mozhdeh Momtahan | Q57617315 |
P2093 | author name string | Bahareh Hamedi | |
Pouya Farhadi | |||
Minoo Robati | |||
Zahra Sarraf | |||
Ahmad Mosalaie | |||
Soodabeh Hooshmand | |||
P2860 | cites work | Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma | Q72036445 |
Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group | Q73507149 | ||
Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma | Q73591116 | ||
National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996 | Q73736849 | ||
Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study | Q74605733 | ||
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma | Q77321080 | ||
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma | Q79420765 | ||
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy | Q79502114 | ||
Survival in cervix cancer patients treated with radiotherapy followed by radical surgery | Q81661363 | ||
Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm | Q81728732 | ||
Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer | Q82234350 | ||
Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) | Q82672660 | ||
[Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB] | Q85647038 | ||
[Surgical treatment of 294 patients with invasive cervical cancer] | Q85649246 | ||
Global cancer statistics | Q22241238 | ||
Neoadjuvant chemotherapy for locally advanced cervix cancer | Q24247192 | ||
Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma | Q25256293 | ||
Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial | Q30440940 | ||
Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications | Q33222996 | ||
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. | Q33334084 | ||
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. | Q34374619 | ||
Human papillomavirus testing in the prevention of cervical cancer | Q34616083 | ||
Radiation-sparing managements for cervical cancer: a developing countries perspective | Q35165643 | ||
Modern management of locally advanced cervical carcinoma | Q35217998 | ||
Fertility-sparing surgery for malignancies in women | Q36077626 | ||
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients | Q37114187 | ||
Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). | Q40477951 | ||
Radical hysterectomy after pelvic irradiation in patients with high risk cervical cancer or uterine sarcoma: morbidity and outcome. | Q40751826 | ||
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). | Q43056474 | ||
Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. | Q44140922 | ||
Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma | Q46923580 | ||
Quality of life and sexual functioning in cervical cancer survivors. | Q51924935 | ||
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. | Q53318977 | ||
Quantitative status of resources for radiation therapy in Asia and Pacific region. | Q53324681 | ||
Results of Hysterectomy in Patients With Bulky Residual Disease at the End of Chemoradiotherapy for Stage IB2/II Cervical Carcinoma | Q61409354 | ||
P433 | issue | 12 | |
P921 | main subject | adaptive radiation therapy | Q180507 |
hysterectomy | Q550675 | ||
cervix uterine cancer | Q160105 | ||
P304 | page(s) | e10758 | |
P577 | publication date | 2013-12-05 | |
P1433 | published in | Iranian Red Crescent medical journal | Q26842886 |
P1476 | title | The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer | |
P478 | volume | 15 |
Q38364617 | Adenocarcinoma of the cervix: should we treat it differently? |
Q51837679 | Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer. |
Q36556464 | Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer |
Q37536775 | Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation. |
Search more.